BHM vs BMY · rev $68.7M vs P/E 17, rev $24.46B
Bluerock Homes Trust Inc. (BHM) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Bluerock Homes Trust Inc. (BHM) is a reit - residential company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BHM revenue for 2025-12-31 was $68.7M. Net income was -$32.6M. Revenue was up 36.9% from 2024-12-31 to 2025-12-31. BHM currently screens at market cap $40.1M.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BHM currently screens at market cap $40.1M. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BHM and BMY stock pages for the full models.
Not investment advice.